Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 4-[(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-pyridin-2-ylbenzenesulfonamide | Ki | 7970.0 [1] | |
| 4-[(2-Amino-3-chloro-4-hydroxy-5-methylphenyl)diazenyl]-N-pyridin-2-ylbenzenesulfonamide | Ki | 6560.0 [1] | |
| N-[3-(3-Methyl-4-Oxo-4,5,6,7-Tetrahydro-2h-Isoindol-1-Yl)-4-Phenoxyphenyl]methanesulfonamide | IC50 | 1000.0 [1] | |
| (3E)-3-(Piperidin-1-ylmethylidene)-1,2-dihydropyrrolo[1,2-a]quinazolin-5-one | IC50 | 6200.0 [1] | |
| (3E)-3-(Pyrrolidin-1-ylmethylidene)-1,2-dihydropyrrolo[1,2-a]quinazolin-5-one | IC50 | 9600.0 [1] | |
MLA | "Quest Database™ Transcription activator BRG1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/transcription-activator-brg1-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 15). Quest Database™ Transcription activator BRG1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/transcription-activator-brg1-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |